HomeLifestyleFood & BeverageModerna (MRNA) Could Struggle This Year & Outlook For Weight Loss Drugs

Moderna (MRNA) Could Struggle This Year & Outlook For Weight Loss Drugs

We expect Moderna (MRNA) to launch multiple products in 2025, notes Lee Brown. He discusses vaccine stocks in focus. He talks about how MRNA posts a wider loss and cuts guidance as Covid vaccine sales drop. Brown also goes over how new RSV and flu vaccines are expected from MRNA. He expects MRNA to struggle to compete this year with GSK and PFE. He then looks at the outlook for weight loss drugs, highlighting Eli Lilly (LLY). Tune in to find out more about the stock market today.

Morning Trade Live

02 Nov 2023

SHARE

ON AIR
11:00 am
Fast Market
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
ON AIR
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
education
7:30 pm
Your First Trade
REPLAY
8:00 pm
Trading 360
REPLAY
9:00 pm
Market Overtime
REPLAY
education
9:30 pm
Your First Trade
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now